Risk Factors for Thrombosis in Children With Central Venous Lines
NCT ID: NCT04117217
Last Updated: 2024-11-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2017-03-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Use of Coated Venous Catheters in the Critically Ill Child
NCT00202813
Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
NCT01737554
Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients
NCT01343680
Novel Strategy to Encourage Early Removal of Central Venous Catheters
NCT04136561
Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients
NCT04559334
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Central venous lines
Patients having a central venous catheter placed at Banner University Medical Center, University of Arizona
Labs drawn
We will collect blood samples/biomarkers at the time of enrollment.
Cardiac catheterization
Patients undergoing a cardiac catheterization procedure done at Banner University Medical Center, University of Arizona
Labs drawn
We will collect blood samples/biomarkers at the time of enrollment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Labs drawn
We will collect blood samples/biomarkers at the time of enrollment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having a central venous catheter or cardiac catheterization performed
Exclusion Criteria
* patients with hemophilia A or B
6 Months
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1701146088R002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.